[Federal Register Volume 62, Number 107 (Wednesday, June 4, 1997)]
[Notices]
[Page 30605]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-14513]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Pursuant to Section10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
National Cancer Institute Special Emphasis Panel (SEP) meeting:
Name of SEP: Phase I Trials of Anti-Cancer Agents.
Date: July 21-23, 1997.
Time: July 21--7:00 p.m. to 10:00 p.m., July 22-23--8:00 a.m. to
5:00 p.m.
Place: Embassy Suites Chevy Chase Pavilion, 4300 Military Road,
N.W., Washington, D.C. 20015.
Contact Person: Ray Bramhall, Ph.D., Scientific Review
Administrator, National Cancer Institute, NIH Executive Plaza North,
Room 643, 6130 Executive Boulevard, MSC 7410, Bethesda, MD 20892-
7410, Telephone: 301/496-3428.
Purpose/Agenda: To evaluate and review grant applications.
The meeting will be closed in accordance with the provisions set
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.
Applications and the discussions could reveal confidential trade
secrets or commercial property such as patentable material and
personal information concerning individuals associated with the
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
(Catalog of Federal Domestic Assistance Program Numbers: 93.393,
Cancer Cause and Prevention Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396,
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398,
Cancer Research Manpower; 93.399, Cancer Control)
Dated: May 28, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-14513 Filed 6-3-97; 8:45 am]
BILLING CODE 4140-01-M
